The Archive

Everything we've published

475 articles across your industry — the developments, rule changes, and moves that touch your business. Browse by section, or search for what you need.

Regulatory

AbbVie Launches Phase 2 Forehead Lines Study Aug 24, 2026
Revance Wins FDA Nod for Under-Eye Injectables Aug 23, 2026
CKD Bio Pursues China Botox Approval—2027 Launch Targeted Aug 22, 2026
AEON Releases Expanded Data on ABP-450 Botox Biosimilar Aug 20, 2026
Numeco Wins Panama Approval for Newlux Botulinum Toxin Aug 20, 2026
BOTOX Masseter Indication Moves Closer to FDA OK Aug 17, 2026
Botox Masseter Indication Moves Closer to FDA OK Aug 11, 2026
FDA Accepts BOTOX Cosmetic sBLA for Masseter Prominence Aug 10, 2026
FDA Accepts BOTOX Masseter sBLA—Jawline Approval Path Clear Aug 9, 2026
AbbVie Wins FDA Review for BOTOX Jawline Indication Aug 7, 2026
FDA Accepts sBLA for Botox in Masseter Prominence Aug 6, 2026
AbbVie Wins FDA Review for BOTOX Jawline Indication Aug 5, 2026
Indiana Tightens Medical Spa Regulations Under Public Law 136 Jul 29, 2026
SKINVIVE by JUVÉDERM Gains FDA Approval for Neck Lines—New Indication Expands Filler Market Jul 27, 2026
AbbVie Sues Galderma Over Patented Dermal Filler Syringe Designs Jul 25, 2026
AbbVie Wins EU Approval for Boey, Its Rapid-Onset Botulinum Toxin Jul 24, 2026
AbbVie Wins EU Approval for Boey, Its Short-Acting Botulinum Toxin Jul 22, 2026
Medicare Begins Price Negotiation on Botox and 14 Other Drugs — Regulatory Headwind for Toxin Economics Jul 18, 2026
Medicare Begins Price Negotiation for Botox and 14 Other Drugs — Reimbursement Pressure Ahead Jul 16, 2026
Medicare Adds Botox to Price-Negotiation List — What Payers Negotiating Toxin Costs Means for Your Reimbursement Jul 15, 2026
Galderma Provides Update on Relabotulinum BLA — Third Toxin Competitor Advances Toward FDA Approval Jul 12, 2026
Galderma Updates Relabotulinum BLA Status With FDA — Third Neuromodulator Nears U.S. Approval Jul 11, 2026
Galderma Provides Update on RelabotulinumtoxinA BLA Review — Third Botulinum Toxin Competitor Advances Jul 11, 2026
Galderma's Relfydess Botox Rival Hits FDA Roadblock — What Practices Need to Know Jul 7, 2026
Galderma Gets Complete Response Letter on RelabotulinumtoxinA — What Went Wrong Jul 5, 2026
Galderma Receives Complete Response Letter for Relfydess — Botox Rival Faces Regulatory Hurdle Jul 4, 2026

Business & M&A

Allergan Aesthetics Overhauls Loyalty Program Aug 24, 2026
Evolus Expands Estyme to Canada, Australia, New Zealand Aug 24, 2026
Evolus Q2 Revenue Beats Forecast, Raises 2026 Outlook Aug 21, 2026
AbbVie Files Material Event on Allergan Aesthetics Aug 20, 2026
Evolus Posts Third Straight Profitable Quarter Aug 19, 2026
Allergan Refreshes Partner Privileges Loyalty Aug 19, 2026
Allergan Adds Quarterly Botox Rebate for Growth Aug 18, 2026
Rejuran Maker PharmaResearch Acquires Cosmetic Group Aug 18, 2026
Allergan Aesthetics Refreshes APP Loyalty Program Aug 17, 2026
Evolus Posts Break-Even Q2—Path to Sustained Profit Clear Aug 16, 2026
Beauty Health Q2 Earnings: Device Demand Steady Aug 14, 2026
Establishment Labs Raises 2026 Revenue Guidance Aug 14, 2026
Evolus Tops Q2 Revenue Forecast, Raises 2026 Outlook Aug 12, 2026
Allergan Refreshes Partner Privileges Loyalty Program Aug 12, 2026
Indonesia Opens First Botulinum Toxin Plant Aug 11, 2026
Galderma Raises 2026 Guidance After Robust H1 Aug 11, 2026
Evolus Posts Third Straight Profitable Quarter Aug 10, 2026
Evolus Q2 Revenue Surges 21%, Adjusted EBITDA Swings Positive Aug 10, 2026
Perceptive Advisors Takes New Stake in Evolus Aug 10, 2026
Evolus Q2 Revenue Hits $84.1M, Raises 2026 Guidance Aug 9, 2026
Hugel Posts Record H1 Earnings on Toxin Growth Aug 8, 2026
AbbVie Files Material Event—Allē Rebate Terms Shifting Aug 7, 2026
Evolus Files Material Event—Jeuveau Pricing Escalates Aug 7, 2026
Evolus Posts Third Straight Profitable Quarter, Raises Outlook Aug 6, 2026
Evolus Files Material Event—Jeuveau Pricing Shift Ahead Aug 5, 2026
Galderma Raises 2026 Guidance After $3.1B H1 Sales Aug 4, 2026
Steel Partners Escalates InMode Pressure Over Governance Aug 2, 2026
Berenberg Backs Galderma's Integrated Model After H1 Beat Aug 1, 2026
RBC Lifts Galderma Outlook Following H1 Beat Aug 1, 2026
AbbVie Files Material Event—Botox/Juvéderm Pricing Shift Ahead Jul 31, 2026
Hugel Aesthetics Launches Direct Sales Force for Letybo, Expands US Footprint Jul 29, 2026
Galderma Posts $3.1B H1 Sales, Raises 2026 Outlook Jul 28, 2026
Hugel Aesthetics Builds U.S. Direct Sales Force for Letybo and K-TOX Campaign Jul 28, 2026
Hugel Launches Letybo in India, Expanding Asia-Pacific Footprint Jul 25, 2026
Hugel Aesthetics Builds U.S. Footprint with Direct Sales Force for Letybo and K-TOX Campaign Jul 25, 2026
Hugel Aesthetics Builds Direct Sales Force for Letybo and K-TOX in U.S. Market Jul 24, 2026
Galderma Posts Record H1 2026 Sales of $3.1B, Raises Full-Year Guidance Jul 24, 2026
Steel Partners Offers $16.75 Per Share for InMode—Device Consolidation Accelerates Jul 23, 2026
Hugel Expands US Footprint With Direct Sales Force for Letybo and New K-TOX Campaign Jul 22, 2026
Steel Partners Offers to Acquire InMode at $16.75 Per Share; Board Evaluates Rival Bids Jul 22, 2026
InMode Reports Q2 Revenue $95.2–$95.4M — Steady Growth Amid Acquisition Uncertainty Jul 21, 2026
Galderma Launches Alastin in Japan, Asia-Pacific Markets Jul 21, 2026
Steel Partners Bids $16.75 Per Share for InMode — What a Takeover Means for Device Buyers Jul 20, 2026
InMode Guides Q2 2026 Revenue to $95.2M–$95.4M, Reiterates $365M–$375M Full-Year Target Jul 17, 2026
Court Bid Filed to Pause InMode Takeover Review — Shareholder Litigation Clouds Steel Partners Offer Jul 16, 2026
Steel Partners Bids $16.75/Share for InMode — What a Takeout Means for Device Economics Jul 16, 2026
L'Oréal Raises Galderma Stake to 20%, Deepening Strategic Investment Jul 15, 2026
InMode Guides Q2 Revenue to $95.2M–$95.4M, Reiterates $365M–$375M FY 2026 Target Jul 15, 2026
Steel Partners Bids $16.75/Share for InMode — Challenging CEO Buyout Jul 15, 2026
Steel Partners Bids $16.75/Share for InMode — What a Hostile Takeover Means for Device Buyers Jul 14, 2026
L'Oréal Raises Galderma Stake to 20% — What Luxury-Goods Capital Means for Aesthetic Pricing Jul 14, 2026
Sisram Medical Restructures DAXXIFY China Deal With Fosun — Supply Chain Shift Signals Market Consolidation Jul 14, 2026
L'Oréal Raises Galderma Stake to 20% — Strategic Beauty-Pharma Convergence Play Jul 13, 2026
Sisram Medical Restructures DAXXIFY China Deal With Fosun — Botulinum Toxin Strategy Shifts Jul 13, 2026
Steel Partners Offers $16.75/Share for InMode — Rival Bid Challenges CEO Buyout Jul 13, 2026
L'Oréal Boosts Galderma Stake to 20% — Strategic Consolidation in Aesthetics Jul 12, 2026
Sisram Medical Restructures DAXXIFY China Deal With Fosun Unit — Supply Chain Complexity Deepens Jul 12, 2026
Steel Partners Bids $16.75/Share for InMode — What a Contested Takeover Means for Device Buyers Jul 11, 2026
AbbVie Allergan Aesthetics Files Material Event — Botox and Juvéderm Pricing or Loyalty Changes Likely Jul 11, 2026
Evolus Files Material Event on Jeuveau Loyalty Program — Pricing and Rebate Moves Signal Market Pressure Jul 11, 2026
Steel Partners Bids $16.75 Per Share for InMode — Unsolicited Offer Challenges CEO Buyout Jul 10, 2026
InMode Receives Unsolicited Takeover Offer — Consolidation Pressure Mounts in Device Market Jul 8, 2026
AbbVie Files Material 8-K on Allergan Aesthetics — Pricing or Rebate Shift Likely Ahead Jul 7, 2026
L'Oréal Boosts Galderma Stake to 20% — Strategic Bet on Aesthetics and Skincare Convergence Jul 7, 2026
InMode Receives Unsolicited Takeover Offer — Consolidation Pressure Mounts in Energy-Device Space Jul 7, 2026
AbbVie Files Material Event on Allergan Aesthetics — Pricing or Rebate Move Likely Incoming Jul 7, 2026
InMode Confirms Receipt of Unsolicited Takeover Proposal — Strategic Interest Signals Market Consolidation Jul 6, 2026
InMode Receives Unsolicited Buyout Proposal at $16.20 per Share — M&A Signals Consolidation Pressure Jul 6, 2026
Evolus Files Material Events — Jeuveau Pricing and Evolus Rewards Program Under Strategic Review Jul 3, 2026
AbbVie Files Multiple Material Events — Botox/Juvéderm Pricing and Rebate Moves Signal Margin Pressure Jul 3, 2026
L'Oréal Increases Stake in Galderma to 20% — Consolidation Pressure Mounts in Aesthetics Jul 3, 2026
AbbVie Allergan Aesthetics Files Multiple Material Events — Botox/Juvéderm Pricing or Allē Loyalty Shifts Imminent Jul 2, 2026
L'Oréal Boosts Galderma Stake to 20% — Strategic Consolidation in Premium Filler Market Jul 2, 2026
Evolus Files Material Event — Jeuveau Pricing or Loyalty Program Shift Likely Jul 2, 2026
AbbVie Files Multiple Material Events — Botox/Juvéderm Pricing or Rebate Adjustments Likely Jul 1, 2026
Evolus Files Material Event: Jeuveau Loyalty Program Signals Aggressive Medspa Push Jun 30, 2026
AbbVie Files Multiple Material Events — Botox/Juvéderm Pricing or Rebate Moves Imminent Jun 30, 2026
Allergan Aesthetics Files Multiple Material Events: Pricing and Rebate Moves Signal Margin Pressure Jun 29, 2026
Evolus Files Multiple Material Events — Jeuveau Pricing Strategy Intensifies Jun 29, 2026
AbbVie Files Multiple Material Events — Allergan Aesthetics Pricing and Rebate Moves Signal Margin Pressure Across Injectable Market Jun 28, 2026
Evolus Files Multiple Material Events — Jeuveau Pricing and Loyalty Program Moves Target Medspa Market Share Jun 28, 2026
AbbVie's Allergan Aesthetics Files Multiple Material Events — Pricing and Rebate Moves Ahead Jun 27, 2026
Evolus Files Multiple Material Events — Jeuveau Competitive Moves Underway Jun 27, 2026
AbbVie Files Multiple Material Events — Allergan Aesthetics Pricing or Rebate Moves Likely Ahead Jun 27, 2026
Evolus Files Multiple Material Events — Jeuveau Competitive Pricing Strategy in Motion Jun 27, 2026
Medspa Franchise vs Independent Practice: Cost, Control, and Unit Economics Jun 26, 2026
Should Your Medspa Have a Membership Program? Models, Metrics, and Revenue Impact Jun 26, 2026
How to Market a Medspa: High-Converting Channels and Real Unit Economics Jun 26, 2026
How Much Revenue Can One MedSpa Treatment Room Generate? Jun 26, 2026
How Much Does It Cost to Open a Medspa? Real Buildout, Device, and Staffing Numbers Jun 26, 2026
Boulevard vs Aesthetic Record vs PatientNow: Which Medspa Software Fits Your Practice Jun 26, 2026
What It Takes to Open a Medical Spa: Licensing, Medical Director, Ownership, and Capital Requirements Jun 26, 2026
How to Price Lip Filler at Your MedSpa: Cost Inputs, Market Rates, and Packaging Strategy Jun 26, 2026
Medspa Profit Margins: What's Normal by Service Line Jun 26, 2026
Botox Cost Per Unit and Profit Margin: The Real Economics for Medspa Owners Jun 26, 2026
InMode Receives Unsolicited $16.20-Per-Share Acquisition Proposal — Device Consolidation Accelerates Jun 26, 2026
Med Spa Valuation and Exit Basics: What Makes a Practice Worth Buying Jun 6, 2026

Devices & Tech

Sofwave Hits One Million Treatments Milestone Aug 24, 2026
Ultherapy PRIME Real-Time Imaging Reshapes Midface Lifting Aug 23, 2026
XERF Technology Enters Australian Market for Skin Tightening Aug 22, 2026
Sisram Medical H1 2026: APAC Growth Offsets Margin Pressure Aug 21, 2026
Sofwave Hits One Million Treatments Globally Aug 20, 2026
Ultherapy PRIME Clears FDA for Knee Skin Aug 19, 2026
FDA Clears Ultherapy PRIME for Knee Skin Laxity Aug 17, 2026
Apyx: GLP-1 Boom Is Fueling Renuvion Demand Aug 16, 2026
Merz Ultherapy PRIME Clears FDA for Knee Skin Laxity Aug 15, 2026
Alma Launches TitaniumLift™ Multi-Depth RF Protocol Aug 14, 2026
InMode Q2 Revenue Beats at $95.6M on Device Demand Aug 13, 2026
Ultherapy PRIME Clears FDA for Knee Skin Laxity Aug 12, 2026
Apyx Sees GLP-1 Boom Fueling Body Contouring Demand Aug 12, 2026
InMode Q2 Beats EPS Forecast, Revenue Tops Estimates Aug 9, 2026
InMode Q2 Revenue Beats Estimates at $95.6M Aug 8, 2026
Sofwave Q2 Revenue Accelerates on Ultrasonic Demand Aug 8, 2026
InMode Q2 Revenue Beats on Steady U.S. Device Demand Aug 7, 2026
InMode Q2 Beats on Steady U.S. Device Demand Aug 6, 2026
Sofwave Q2 Revenue Accelerates on Ultrasonic Demand Aug 6, 2026
Sofwave Q2 Revenue Jumps 43% YoY to $30M Aug 5, 2026
InMode Q2 Flat Revenue, Margins Compress Aug 5, 2026
RF Microneedling Adverse Events Draw Clinical Review Aug 4, 2026
Indonesia Opens Botulinum Toxin Plant—2028 Production Aug 3, 2026
SkinStylus Gets FDA Nod for Periorbital Wrinkles Aug 2, 2026
Alma Lasers Launches Harmony Platform in India—Multi-Modality Push Jul 31, 2026
Aesthetic Lasers Market Projected to Hit $11.1B by 2036 Jul 30, 2026
Alma Lasers Launches Harmony Platform in India, Signals Multi-Modality Strategy Jul 29, 2026
Galderma Rolls Out Alastin Regenerative Skincare Across JPAC Region Jul 20, 2026
Cynosure Launches XERF Monopolar RF Platform in Europe — Next-Gen Skin Tightening Enters Market Jul 20, 2026
Cynosure Launches XERF Monopolar RF Platform in Europe — Next-Gen Skin Tightening Competes with Thermage Jul 16, 2026
Cynosure Lutronic Launches XERF Monopolar RF Platform in Europe Jul 16, 2026
Cynosure Lutronic Launches Next-Generation Monopolar RF in Europe — Non-Invasive Skin Tightening Demand Accelerates Jul 13, 2026
Cynosure Lutronic's XERF Accelerates Adoption as Leading Monopolar RF Platform — Competitive Pressure on InMode Jul 12, 2026
Hugel's Botulinum Toxin Manufacturing Scales to 25,000 Vials From Thumb-Sized Tube — Supply Dynamics Shift Jul 12, 2026
Hugel's Toxin Manufacturing Scales to 25,000 Vials From a Thumb-Sized Tube — Supply Chain Efficiency Jul 12, 2026
SkinStylus Receives FDA Clearance for Periorbital Wrinkles Across All Skin Types Jul 11, 2026
Cynosure Lutronic's XERF Gains Traction as Monopolar RF Leader — Market Share Shift in Body Contouring Jul 11, 2026
Fotona Reports Surge in Younger Patient Bookings for 'Collagen Banking' — Preventive Laser Trend Gains Traction Jul 11, 2026
Cynosure Lutronic's XERF Monopolar RF Platform Gains Rapid Adoption Across North America Jul 11, 2026
Fractional RF Microneedle Market Valued at $2.3B — Device Consolidation Accelerates Jul 7, 2026
Fotona4D Reports Surge in Younger Patient Bookings — 'Collagen Banking' Trend Reshapes Device Mix Jul 7, 2026
Fotona4D Reports Surge in Younger Patient Bookings — 'Collagen Banking' Trend Reshapes Device Mix Jul 7, 2026
Sisram Medical Launches China Manufacturing for Alma Rejuve — Localized Production Begins Jul 6, 2026
Sisram Medical Launches China Manufacturing for Alma Rejuve — Supply Chain Shift Underway Jul 6, 2026
Queen City Dermatology Becomes First Cincinnati Practice to Offer XERF Radiofrequency Jul 4, 2026
Cynosure's XERF Radiofrequency Now 3x Faster — Adoption Accelerates Across Clinics Jul 4, 2026
XERF Radiofrequency Adoption Accelerates — Cynosure Lutronic's Speed Advantage Reshapes Device Economics Jun 29, 2026
Cynosure Lutronic's XERF Radiofrequency System Sees Accelerating Adoption — Now 3x Faster Processing Speed Jun 28, 2026
Cynosure Lutronic's XERF Radiofrequency Now 3x Faster — Device Economics Shift Jun 27, 2026
XERF Radiofrequency Adoption Accelerates — Cynosure Lutronic Reports 3x Speed Improvement Jun 27, 2026
Aesthetic Laser Costs: Price Ranges by Modality and Break-Even Economics Jun 26, 2026
CoolSculpting vs Emsculpt vs truSculpt vs SculpSure: Body-Contouring ROI for Medspa Owners Jun 26, 2026
HydraFacial vs. Regular Facial: Clinical Mechanism, Economics, and Menu Positioning for Medspa Owners Jun 26, 2026
Microneedling vs RF Microneedling: Clinical Depth, Energy Delivery, Results, and Device ROI for Practice Owners Jun 26, 2026
Exosomes in Aesthetics: What the Science Shows and Why the FDA Hasn't Approved Them Jun 26, 2026
Ellacor: How Candela's Micro-Coring Technology Works and What FDA Approval Means for Your Practice Jun 26, 2026
Emsculpt NEO: HIFEM + RF Body Contouring for Medspa Owners Jun 26, 2026
Emface: How BTL's Needle-Free HIFES + RF Lift Works and What It Means for Your Practice Jun 26, 2026
Morpheus8 Machine Cost: Acquisition, Consumables, and Break-Even Patient Volume Jun 26, 2026
What Is Sofwave? How Ultrasound Microthermal Therapy Works for Skin Tightening Jun 26, 2026
PDO Thread Lifts: How They Work, Results, Longevity, and Risk Profile Jun 26, 2026
PRP vs PRF in Aesthetics: Preparation, Clinical Uses, and Evidence Jun 26, 2026
RF Microneedling: How It Works, Clinical Indications, and Leading Devices Jun 26, 2026
What Is Morpheus8? RF Microneedling Technology, Clinical Applications, and Practice Economics Jun 26, 2026
Ultherapy vs Sofwave: Comparing Ultrasound and Radiofrequency Skin Tightening Jun 26, 2026
CoolSculpting vs Emsculpt: Mechanisms, Results, and Practice Economics Jun 26, 2026
Morpheus8 vs. Vivace: RF Microneedling Depth, Results, and Practice ROI Compared Jun 26, 2026
The Used / Gray-Market Device Question: Service Lockouts, Liability, and When It's a Trap Jun 24, 2026
The Body Contouring Buy Decision: Cryolipolysis vs RF vs HIFU vs Muscle-Stim on Demand and Repeat Rate Jun 21, 2026
Warranty and Service-Contract Negotiation: The Clauses That Cost You Later Jun 19, 2026
Device ROI Models That Actually Hold Up: Treating $/Pulse, Consumables, and Downtime as Real Costs Jun 15, 2026
Reading a Device Clinical Claim: '510(k) Cleared For' vs What the Rep Is Implying It Does Jun 13, 2026
Lease vs Finance vs Buy on a $120K Platform: The Tax and Cash-Flow Math Reps Won't Show You Jun 10, 2026
What Is a 'Vampire Facial'? The PRP Treatment Behind the Name, for Owners Jun 9, 2026
Chemical Peel vs Microdermabrasion: Matching Exfoliation Intensity to the Patient Jun 8, 2026
IPL vs BBL: Understanding the Light-Based Options Patients Ask About Jun 8, 2026
Microneedling vs Laser Resurfacing: Two Routes to Skin Renewal, Different Intensity and Cost Jun 7, 2026
What Is Microchanneling? Understanding a Microneedling-Adjacent Treatment Jun 7, 2026
The Consumables Trap: Why 'Cheap' Energy Devices With Per-Tip Costs Beat You on Margin Jun 7, 2026
Muscle vs Fat Body Contouring: Comparing Energy-Based Approaches for Owners Jun 6, 2026
HydraFacial vs Dermaplaning: Two Popular 'Glow' Treatments Compared Jun 5, 2026
How Much Does CoolSculpting Cost — and Does the Device Math Work for Your Practice? Jun 5, 2026
CoolSculpting vs Liposuction: Non-Invasive Device vs Surgical Fat Removal Jun 4, 2026
How Much Does Microneedling Cost — and How Owners Should Price the Series Jun 4, 2026
How Many Microneedling Sessions — Framing the Series for Results and Revenue Jun 4, 2026
Laser vs IPL for Pigmentation: Choosing the Right Light for the Concern Jun 4, 2026
Chemical Peel vs Laser Resurfacing: Matching the Treatment to the Patient and the Downtime Jun 4, 2026
Microneedling vs Chemical Peel: Two Routes to Better Skin Texture Jun 3, 2026
PRP vs Microneedling: How They Differ and Why They're Often Done Together Jun 3, 2026
Laser Hair Removal vs Electrolysis: Two Approaches to Hair Reduction Jun 2, 2026
PRP for Hair Restoration: An Owner's Overview of a Growing Service Line Jun 2, 2026

Injectables

AEON Releases Expanded ABP-450 Botox Biosimilar Data Aug 23, 2026
RHA Redensity Eye Wins FDA Nod for Under-Eye Hollows Aug 21, 2026
Juvéderm Day Returns With Significant Filler Pricing Aug 21, 2026
Daxxify Duration Claims vs. Reality Aug 19, 2026
Galderma Wins EU Nod for Restylane Shaype Aug 18, 2026
MOLD Manila Rolls Out Radiesse for Facial Rejuvenation Aug 17, 2026
AbbVie's Botox Sales Surge—What's Driving the Revival Aug 17, 2026
Hugel Posts Record H1 on Toxin Surge—Overseas Growth Accelerates Aug 16, 2026
Galderma Wins EU Nod for Restylane Shaype Aug 15, 2026
Hugel Debuts Thechaum Signature with Reduced Crosslinker Aug 15, 2026
GLP-1 Boom Exposed Filler Limitations—Here's Why Aug 15, 2026
Galderma Chief: Start GLP-1 Patients on Skin Care First Aug 14, 2026
Evolus' Injectable Platform Is Becoming Its Real Moat Aug 13, 2026
AbbVie Launches Boey, Rapid-Onset Toxin, in Europe Aug 4, 2026
JUVÉDERM Day Returns August 19—Promo Details Aug 3, 2026
SKINVIVE Neck-Line Indication Expands Filler Market Aug 3, 2026
Galderma Launches Sculptra in India—Regenerative Expansion Aug 3, 2026
AbbVie Q2 2026: Aesthetics Growth Outpaces Pharma Aug 2, 2026
Evolus Q2 2023: Revenue Breakdown Signals Jeuveau Stabilization Jul 30, 2026
Daewoong's Nabota Reaches 1 Trillion Won in Cumulative Sales, Signals Korean Toxin Momentum Jul 29, 2026
AbbVie Launches Boey, Rapid-Onset Botulinum Toxin, With EU Approval Jul 28, 2026
Xeomin Enters Neurotoxin Resistance Conversation as Clinical Data Accumulates Jul 28, 2026
Hugel Builds US Direct Sales Force for Letybo, Launches K-TOX Campaign Jul 23, 2026
Allergan Aesthetics Wins EU Approval for Boey — First Rapid-Onset, Short-Duration Neuromodulator Jul 21, 2026
AbbVie's Boey Wins EU Approval for Frown Lines — First Rapid-Onset Botox Alternative Jul 20, 2026
Daewoong Pharma's Nabota Surpasses 1 Trillion Won in Sales — South Korean Toxin Accelerates Global Expansion Jul 19, 2026
Allergan Aesthetics Wins EU Approval for Boey — First Rapid-Onset, Short-Duration Neuromodulator Jul 19, 2026
Allergan Aesthetics Wins EU Approval for Boey — First Rapid-Onset, Short-Duration Neurotoxin Reshapes Toxin Economics Jul 18, 2026
Evolus Expands Jeuveau Rewards Program — Aggressive Pricing War Targets Medspa Market Share Jul 17, 2026
Evolus Aggressively Markets Jeuveau Through Rewards Program — Neuromodulator Price Wars Intensify Jul 16, 2026
Daewoong Pharma's Nabota Exceeds 1 Trillion Won in Sales, Accelerates Global Push Jul 15, 2026
Evolus Ramps Jeuveau Marketing to Medspas via Evolus Rewards Program Jul 15, 2026
Evolus Aggressively Markets Jeuveau to Medspas via Rewards Program — Price War Signals Intensify Jul 14, 2026
AbbVie Allergan Files Material Event — Botox/Juvéderm Pricing or Rebate Shift Likely Imminent Jul 14, 2026
Evolus Secures Exclusive U.S. License for Profhilo — 15-Year Term, No Upfront Fee Jul 13, 2026
Evolus Secures Exclusive U.S. Profhilo License From IBSA — Skin Quality Injectable Now in Play Jul 12, 2026
Evolus Secures Exclusive U.S. Profhilo License From IBSA — A Skin-Quality Play to Challenge Juvéderm Jul 11, 2026
Evolus Secures Exclusive U.S. Rights to Profhilo From IBSA — 15-Year Term, No Upfront Fee Jul 10, 2026
Allergan Wins FDA Nod for SKINVIVE by JUVÉDERM for Neck — New Indication, Familiar Economics Jul 7, 2026
Allergan Aesthetics Wins FDA Approval for SKINVIVE by JUVÉDERM for Neck — First Indication Expansion Jul 6, 2026
AbbVie Wins FDA Approval for SKINVIVE by JUVÉDERM for Neck — First Filler Indication in Category Jul 4, 2026
FDA Approves Restylane Contour for Temple Hollowing — Galderma Expands Filler Indication Portfolio Jul 3, 2026
FDA Approves Skinvive by Juvéderm for Neck Appearance — AbbVie Expands Filler Portfolio Beyond Face Jul 3, 2026
Galderma Wins FDA Approval for Restylane Contour — Temple Indication Expands Structural Filler Segment Jul 2, 2026
Allergan Aesthetics Wins FDA Approval for Skinvive by Juvéderm — Neck Indication Expands Filler Portfolio Jul 2, 2026
AbbVie Wins FDA Approval for Skinvive by Juvéderm — Neck Indication Expands Filler Portfolio Jul 1, 2026
Galderma Wins FDA Approval for Restylane Contour — Temple Hollowing Indication Expands Filler Anatomy Jul 1, 2026
Galderma Wins FDA Clearance for Restylane Contour — Temple Hollowing Now Indicated Jun 30, 2026
Restylane Contour Approved for Temple Hollowing — Galderma Fills a Clinical Gap Jun 29, 2026
RHA Dynamic Volume Cleared for Midface Augmentation — Revance Expands Dynamic Filler Footprint Jun 29, 2026
FDA Approves Skinvive by Juvéderm for Neck Lines — New Indication Expands Allergan's Dermal Filler Portfolio Jun 28, 2026
Galderma's Restylane Contour Cleared for Temple Hollowing — New Indication, Familiar Filler Jun 28, 2026
Skinvive by Juvéderm Wins FDA Approval for Neck — What's in Your Filler Mix Now Jun 27, 2026
Supply-Disruption Early Warning: Reading 483s and Recalls to Stock Ahead of a Shortage Jun 27, 2026
FDA Approves Skinvive by Juvéderm for Neck Appearance — What the Indication Means for Your Juvéderm Mix Jun 27, 2026
Galderma Wins FDA Clearance for Restylane Contour in Temple Hollowing — Narrower Indication, Broader Competitive Pressure Jun 27, 2026
FDA Clears RHA Dynamic Volume for Midface Augmentation — Revance's Dynamic Filler Gains Broader Indication Jun 27, 2026
How Hyaluronidase Dissolves Filler: Mechanism, Vascular Occlusion Protocol, and Practice Liability Jun 26, 2026
Botox Units Per Area: Standard Dosing and Practice Economics Jun 26, 2026
RHA vs Juvéderm: Resilient HA and Vycross Technology Compared for Aesthetic Practice Jun 26, 2026
Daxxify vs Jeuveau: Duration, Cost, and Clinical Positioning Jun 26, 2026
Botox vs Xeomin: Which Neuromodulator to Stock and Offer Your Patients Jun 26, 2026
What Is a Liquid Facelift? Filler and Toxin Combination Strategy for Medspa Owners Jun 26, 2026
What Is a Skin Booster? Category, Players, FDA Status, and Menu Strategy Jun 26, 2026
Skinvive by Juvéderm: The Microdroplet HA Skin Booster for Cheek Hydration Jun 26, 2026
What Is Rejuran? The Polynucleotide Skin Booster Reshaping the Aesthetic Market Jun 26, 2026
Letybo vs. Botox: Key Differences in Units, Onset, and Clinical Profile for Medspa Owners Jun 26, 2026
Is Relfydess FDA Approved? Status, Mechanism, and How It Compares to Dysport Jun 26, 2026
Is Evolysse FDA Approved? Evolus's HA Filler Line Explained Jun 26, 2026
Sculptra vs Radiesse: Mechanism, Timeline, and Clinical Use Cases for Medspa Owners Jun 26, 2026
Juvéderm vs Restylane: HA Filler Families Compared by Crosslinking, Indication, and Longevity Jun 26, 2026
Daxxify vs Botox: Duration, Cost, and When to Use Each Jun 26, 2026
Botox vs Jeuveau: Which Neuromodulator to Stock and Offer Jun 26, 2026
Botox vs Dysport: Clinical Differences, Dosing, and Economics for Injectors Jun 26, 2026
Is Kybella FDA Approved? Current Status and What Medspa Owners Need to Know Jun 26, 2026
Is Sculptra FDA Approved? Status, Indications, and Clinical Use Jun 26, 2026
Are RHA Fillers FDA Approved? Current Status and Clinical Use Jun 26, 2026
Is Xeomin FDA Approved? Status, Indications, and Clinical Profile Jun 26, 2026
Is Skinvive by Juvéderm FDA Approved? Status, Indications, and Microdroplet Technology Jun 26, 2026
Is Letybo FDA Approved? Status, Mechanism, and Clinical Position Jun 26, 2026
Is Jeuveau FDA Approved? Current Status and Clinical Indications Jun 26, 2026
Is Daxxify FDA Approved? Status, Indications, and How It Compares to Botox Jun 26, 2026
Allergan Aesthetics Wins Health Canada Approval for Boey — Rapid-Onset Neuromodulator Clears Regulatory Hurdle Jun 26, 2026
Allergan Aesthetics Wins FDA Approval for Skinvive by Juvéderm — Neck Wrinkles Now Cleared Jun 26, 2026
RHA Dynamic Volume Wins FDA Clearance for Midface Augmentation — New Rheology Profile Enters Market Jun 26, 2026
Biostimulator Supremacy: Why Sculptra-Class Products Are Eating Filler's Lunch Jun 26, 2026
Manufacturer Contract Season: How to Negotiate Volume Tiers Before You Re-Sign Jun 23, 2026
Building a Tox-and-Filler Loyalty Stack: Layering Allē, Aspire, and Evolus Rewards Without Cannibalizing Margin Jun 22, 2026
Anticipating the Next Injectable Price Increase: The Signals That Precede a List-Price Hike Jun 19, 2026
Hyaluronidase Protocols: Stocking, Dosing, and the Vascular-Occlusion Emergency Kit Every Room Needs Jun 18, 2026
Filler Rheology for Owners: G-Prime, Cohesivity, and Why It Dictates Which Product for Which Plane Jun 16, 2026
Switching Your Tox: The Operational Playbook for Inventory, Retraining, Patient Comms, and the Rebate Reset Jun 14, 2026
Cannula vs Needle Economics and Liability: When the Safer Technique Is Also the Better Margin Jun 13, 2026
Managing Tox Resistance and Neutralizing Antibodies: Counseling the Patient and Switching Formulations Jun 12, 2026
The Real Cost-Per-Unit Breakdown: Botox vs Dysport vs Jeuveau vs Daxxify vs Letybo (Loaded, Not List) Jun 12, 2026
Dysport-to-Botox Conversion Ratios in Practice: Pricing and Dosing When You Run Both Jun 11, 2026
Kybella vs CoolSculpting for the Double Chin: Injectable vs Device for Submental Fat Jun 9, 2026
Reconstitution & Dilution Economics: How Your Saline Volume Quietly Changes Your Cost-Per-Unit Jun 9, 2026
How Long Does Botox Take to Work — and Why the Answer Is a Retention Tool Jun 8, 2026
Overfill Math: Getting 22–25 Units Out of a '20-Unit' Vial Without Compromising Results Jun 8, 2026
Jawline Definition: The Treatment Options and the Consult That Sells the Plan Jun 7, 2026
PRF vs Filler for the Under-Eye: Two Approaches to a Delicate Area Jun 7, 2026
Diffusion Profiles That Matter Chairside: Why Field-of-Effect Changes Your Injection Map by Product Jun 7, 2026
Restylane vs RHA: How Owners Should Think About Two HA Filler Families Jun 7, 2026
Radiesse vs Hyaluronic Acid Filler: Biostimulator-Type vs HA Volume Jun 6, 2026
Treating Under-Eye Concerns: Matching the Approach to the Cause (an Owner's Overview) Jun 6, 2026
Dysport vs Daxxify: Diffusion and Duration as the Two Axes That Matter Jun 6, 2026
'Baby Botox' vs Traditional Dosing: Subtlety as a Treatment Philosophy Jun 5, 2026
How Long Does Dysport Last — and Using Onset and Duration to Set Expectations Jun 5, 2026
Thread Lift vs Filler: Lift vs Volume, and Setting the Right Patient Expectation Jun 5, 2026
Filler vs Fat Transfer: Injectable Volume vs a Surgical Approach Jun 3, 2026
How Long Does Lip Filler Last — and How Owners Should Use That for Rebooking Cadence Jun 3, 2026
Lip Flip vs Lip Filler: Two Different Treatments Patients Constantly Confuse Jun 2, 2026
How Much Does Sculptra Cost — and How Owners Should Price the Biostimulator Series Jun 2, 2026
Semaglutide vs Tirzepatide for Medspas: What Owners Need to Know About Offering Each Jun 2, 2026
How Much Does Lip Filler Cost — and How Owners Should Frame Lip Pricing Jun 1, 2026
Dysport vs Jeuveau: Two Neurotoxin Alternatives in Different Lanes Jun 1, 2026
Botox vs Fillers: When Each Is the Right Tool (and Why Patients Confuse Them) Jun 1, 2026

Market

GLP-1 Pill Era Is Forcing Beauty Market Shift Aug 23, 2026
Arm Fat Now Top Body Sculpting Concern in Singapore Aug 22, 2026
Facial Rejuvenation Market Forecast to Hit $5.66B by 2030 Aug 22, 2026
Medytox Q2 Sales Up 11%, Operating Profit Down 25% Aug 13, 2026
Hugel Posts Record H1 Revenue on Overseas Toxin Surge Aug 13, 2026
South Korea's Big Three Post ₩225.9B Q2 Revenue Aug 11, 2026
Daewoong's NABOTA Enters Seventh Middle East Market Aug 9, 2026
Daewoong's Nabota Completes 7-Market GCC Sweep Aug 4, 2026
GLP-1 Weight Loss Boom Lifts Galderma Aesthetics Sales 25% Jul 31, 2026
Daewoong's Nabota Enters Kuwait—Completes 7-Market GCC Sweep Jul 31, 2026
Daewoong's Nabota Enters Kuwait—7th Middle East Market Jul 30, 2026
Galderma Capitalizes on GLP-1 Weight-Loss Trend—What Practices Need to Know Jul 27, 2026
Daewoong's Nabota Hits 1 Trillion Won in Cumulative Sales—Asian Toxin Market Matures Jul 27, 2026
"Ozempic Face" Facials Driving Botox Boom as GLP-1 Users Seek Preventive Aesthetics Jul 27, 2026
Galderma Capitalizes on GLP-1 Weight Loss Trend—What Practices Should Know Jul 26, 2026
Daewoong's Nabota Crosses 1 Trillion Won in Cumulative Sales—Asian Toxin Gains Scale Jul 26, 2026
"Ozempic Face" Facials Driving Botox Boom—Practices Capitalize on GLP-1 Side Effect Jul 26, 2026
Galderma Capitalizes on GLP-1 Weight Loss Trend; 'Ozempic Face' Drives Filler and Toxin Demand Jul 25, 2026
Hugel Launches Letybo in India — Expanding Asia-Pacific Footprint Jul 24, 2026
Hugel Launches Letybo in India, Targets 9% Market Share by 2026 Jul 23, 2026
Galderma Raises Full-Year Guidance After Record First-Half Sales of $3.13B Jul 23, 2026
Hugel Launches Letybo in India, Targets 9% Market Share by 2026 Jul 22, 2026
GLP-1 Aesthetic Care Market Projected to Reach $2B by 2030 — New Revenue Stream for Medspa Operators Jul 19, 2026
InMode Guides Q2 Revenue to $95.2M–$95.4M — Growth Resilience Amid Takeover Uncertainty Jul 18, 2026
InMode Projects Q2 Revenue $95.2M–$95.4M, Reiterates $365M–$375M FY 2026 Guidance Jul 16, 2026
GLP-1 Aesthetic Care Market Projected to Hit $2B by 2030 — New Revenue Stream or Threat? Jul 16, 2026
Daewoong's Nabota Hits 1 Trillion Won in Sales — Korean Toxin Maker Accelerates U.S. and Global Expansion Jul 14, 2026
GLP-1 Weight-Loss Boom Drives Post-Bariatric Body Contouring Surge — New Patient Pipeline for Medspas Jul 13, 2026
InMode Guides Q2 2026 Revenue to $95.2M–$95.4M; Full-Year Outlook Holds at $365M–$375M Jul 13, 2026
GLP-1 Weight-Loss Boom Drives Post-Reduction Body Contouring at Medspa Practices — New Revenue Stream Emerging Jul 12, 2026
GLP-1 Weight-Loss Boom Fuels Body-Contouring Volume — Practices Report Surge in Post-Weight-Loss Procedures Jul 12, 2026
GLP-1 Weight Loss Boom Drives Post-Loss Body Contouring Demand at Aesthetic Practices Jul 11, 2026
Fotona4D Reports Surge in Younger Patient Bookings — 'Collagen Banking' Becomes 2026 Trend Jul 4, 2026
Semaglutide Pricing at Medspas: Compounded vs. Branded and What Patients Actually Pay Jun 26, 2026
Semaglutide Face: Why Medspa Owners Should Offer Fillers to GLP-1 Patients Jun 26, 2026
Offering GLP-1 Weight Loss at a Medspa: Sourcing, Compliance, and Revenue Model Jun 26, 2026
GLP-1 Weight Loss Boom Drives 'Semaglutide Face' — Aesthetic Practices Report Surge in Volume Restoration Demand Jun 26, 2026

Compliance

Warning: Unauthorized Injectables Seized in Canada Aug 18, 2026
Evolus Rewards Program Terms Changed—Review Now Aug 8, 2026
Daewoong Tightens Nabota Distribution After Gray-Market Leak Aug 2, 2026
Alert: SkinMedica/Allergan Brand Terms Page Updated — Review Your Loyalty Program Now Jul 7, 2026
SkinMedica/Allergan Program Terms Shifted — Verify Rebate and Loyalty Thresholds Now Jul 7, 2026
Can a Medspa Prescribe Semaglutide? Scope, Regulations, and State Variation Jun 26, 2026
How to Find and Hire a Medical Director for Your Medspa Jun 26, 2026
Do You Need to Be a Doctor to Own a Medspa? Ownership Rules and MSO Structures Jun 26, 2026
Can a Nurse Practitioner Own a Medical Spa? State Rules, CPOM, and MSO Structures Jun 26, 2026
Is Compounded Semaglutide Legal for Medspas? FDA Status, Compounding Rules, and Enforcement Risk Jun 26, 2026
Medical Director Requirements for Medspas: Role, Supervision, and Liability Jun 26, 2026
Can an RN Inject Botox Without a Doctor? State Scope-of-Practice Rules and Supervision Requirements Jun 26, 2026
Good Faith Exam Requirements for Medical Spas: What Owners Need to Know Jun 26, 2026
Non-Compete and Non-Solicit for Injectors: What's Enforceable After the FTC Rule Shakeout Jun 21, 2026
Med Spa Advertising Law: The FTC and State-Board Rules on 'Results,' Testimonials, and Influencer Posts Jun 21, 2026
The Patient Intake and Contraindication Reference: Screening That Prevents the Lawsuit Jun 20, 2026
OSHA in an Aesthetic Practice: The Bloodborne-Pathogen and Hazard Citations Owners Miss Jun 18, 2026
Handling an Adverse Event: The Documentation, Reporting, and Board-Complaint Survival Guide Jun 18, 2026
Corporate Practice of Medicine, Decoded: Why Your Ownership Structure May Be Illegal in Your State Jun 17, 2026
IV Therapy's Regulatory Gray Zone: Compounding, Standing Orders, and the New Scrutiny Jun 16, 2026
HIPAA for Medspas: The Before/After Photo, Texting, and Social-Media Consent Failures That Get Fined Jun 15, 2026
Injectable Storage, Handling, and Cold-Chain Requirements: The Compliance Checklist Jun 14, 2026
Delegation and Incident-To: Who Can Legally Inject in Your State, and the Supervision Tiers Jun 12, 2026
Medical Waste and Sharps Disposal: The Compliance Basic That's Easy to Get Wrong Jun 9, 2026
The 'Tox Party' Compliance Trap: Why Group Events Trigger Good-Faith-Exam and Supervision Problems Jun 9, 2026
Medical Director on Paper vs in Practice: What 'Supervision' Actually Requires in a CPOM State Jun 9, 2026
Emergency Protocols: Being Ready for the Rare, Serious Event Jun 8, 2026
Telehealth in Aesthetics: Where Remote Evaluation Fits and Where It Doesn't Jun 7, 2026
Chart and Documentation Standards: The Records That Protect You When It Matters Jun 6, 2026
Good-Faith Exam Done Right: Building a Defensible Workflow With Telehealth and Standing Orders Jun 6, 2026
The MSO / Management-Services Model: How It's Used, Where It Breaks, and What Regulators Look For Jun 6, 2026

Search Demand

RF Microneedling Market Size and Growth Aug 1, 2026
Can an RN Own a Medical Spa Aug 1, 2026

Marketing

Email and SMS That Aren't Spam: The Lifecycle Flows That Drive Repeat Visits Jun 27, 2026
Reputation Management: Turning Reviews Into Your Strongest Acquisition Channel Jun 25, 2026
Using the Meta Ad Library to See Exactly What Your Competitors Are Promoting Jun 22, 2026
Meta and Google Ads for Aesthetics: CAC Benchmarks and the Creative That Converts Jun 17, 2026
The Compliant Before/After: Posting Results Without Triggering Board or Platform Violations Jun 11, 2026
Before/After Photography: Why Consistent, Quality Images Are a Business Asset Jun 6, 2026
Optimizing Your Google Business Profile: The Single Most Important Local SEO Asset Jun 5, 2026
Med Spa SEO: Ranking for '[Treatment] Near Me' in a Saturated Local Market Jun 4, 2026
Instagram for Med Spas: Building Trust and Demand Without Burning the Channel Jun 2, 2026
The Med Spa Website That Converts: Turning Traffic Into Booked Consults Jun 1, 2026

Growth & Revenue

The Rebooking System: How Top Practices Hit 70%+ Rebooking at Checkout Jun 26, 2026
Reactivation Campaigns: Winning Back the Lapsed Patients Already in Your Database Jun 24, 2026
Building Treatment Packages That Increase AOV Without Discounting Yourself to Death Jun 24, 2026
Retail and Skincare Attach: Turning Medical-Grade Skincare Into Real Margin Jun 23, 2026
The Consultation-to-Treatment Conversion Playbook: Scripts, Pricing Reveals, and Objection Handling Jun 23, 2026
Pricing Psychology for Aesthetics: Anchoring, Per-Unit vs Per-Area, and the Premium Position Jun 19, 2026
Cross-Sell Maps by Service: What to Recommend Next After Tox, After Filler, After a Laser Series Jun 18, 2026
Bundling Injectables With Skincare: Building Higher-Value, Stickier Treatment Plans Jun 8, 2026
Building a Signature Treatment: Differentiation Through a Branded, Owned Offering Jun 8, 2026
Pricing Transparency: How Much to Show, and What It Signals Jun 6, 2026
Knowing Your Patient Segments: Why Not All Patients Are Equally Valuable Jun 5, 2026
Designing a Med Spa Referral Program That Actually Drives Referrals Jun 4, 2026
Competitive Positioning: Choosing What You Are Instead of Competing on Everything Jun 4, 2026
New-Patient Offers: Attracting First Visits Without Training a Discount Habit Jun 3, 2026
Should You Charge a Consultation Fee? The Strategy Behind the Decision Jun 3, 2026
Memberships vs Packages: Which Recurring-Revenue Model Fits Your Practice Jun 1, 2026

Operations

Trends & Forecast

Starting a Med Spa

Everything we've published

By the time it's news, it's too late.